Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Nischalke, Hans Dieter ^a   Schmitz, Volker ^a   Luda, Carolin ^a   Aldenhoff, Katharina ^a   Berger, Cordula ^a   Feldmann, Georg ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a   Nattermann, Jacob ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD BOX M1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; HOMEOBOX B7 PROTEIN; HOMEODOMAIN PROTEIN; IGF 2 MESSENGER RNA BINDING PROTEIN 3; KINESIN; KINESIN FAMILY MEMBER 2C PROTEIN; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE NEK2; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; CANCER DIAGNOSIS; COHORT ANALYSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; GENE; GENE EXPRESSION; HOXB7 GENE; HUMAN; IGF2BP3 GENE; INTERMETHOD COMPARISON; INTRADUCTAL BRUSH CYTOLOGY; MAJOR CLINICAL STUDY; MALE; NEK2 GENE; PANCREAS CANCER; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

AGED; BILE DUCTS; BILIARY TRACT DISEASES; CONSTRICTION, PATHOLOGIC; CYTODIAGNOSIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; RNA-BINDING PROTEINS; ROC CURVE;

EID: 84864655050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042141     Document Type: Article

References (54)

1. Menias CO, Surabhi VR, Prasad SR, Wang HL, Narra VR, et al. (2008) Mimics of cholangiocarcinoma: spectrum of disease. Radiographics 28: 1115-1129.
2. Hann LE, Winston CB, Brown KT, Akhurst T, (2000) Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy. Semin Surg Oncol 19: 94-115.
3. Pugliese V, Conio M, Nicolo G, Saccomanno S, Gatteschi B, (1995) Endoscopic retrograde forceps biopsy and brush cytology of biliary strictures: a prospective study. Gastrointest Endosc 42: 520-526.
4. Schoefl R, Haefner M, Wrba F, Pfeffel F, Stain C, et al. (1997) Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol 32: 363-368.
5. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, et al. (1999) Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 31: 712-717.
6. Ryan ME, Baldauf MC, (1994) Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures. Gastrointest Endosc 40: 133-139.
7. Ryan ME, (1991) Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 37: 139-142.
8. de Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, et al. (2002) Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 56: 720-730.
9. De Bellis M, Sherman S, Fogel EL, Cramer H, Chappo J, et al. (2002) Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). Gastrointest Endosc 56: 552-561.
10. Principe A, Ercolani G, Bassi F, Paolucci U, Raspadori A, et al. (2003) Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma. Hepatogastroenterology 50: 1246-1249.
11. Fishman DS, Tarnasky PR, Patel SN, Raijman I, (2009) Management of pancreaticobiliary disease using a new intra-ductal endoscope: the Texas experience. World J Gastroenterol 15: 1353-1358.
12. Siddiqui AA, Mehendiratta V, Jackson W, Loren DE, Kowalski TE, et al. (2012) Identification of cholangiocarcinoma by using the Spyglass Spyscope system for peroral cholangioscopy and biopsy collection. Clin Gastroenterol Hepatol 10: 466-471; quiz e448.
13. Takano T, Miyauchi A, Matsuzuka F, Liu G, Higashiyama T, et al. (1999) Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used for fine needle aspiration biopsy. J Clin Endocrinol Metab 84: 951-955.
14. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, et al. (1999) Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 59: 4542-4545.
15. Feldmann G, Nattermann J, Nischalke HD, Gorschluter M, Kuntzen T, et al. (2006) Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer. Endoscopy 38: 604-609.
16. Obama K, Ura K, Li M, Katagiri T, Tsunoda T, et al. (2005) Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 41: 1339-1348.
17. Kokuryo T, Senga T, Yokoyama Y, Nagino M, Nimura Y, et al. (2007) Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res 67: 9637-9642.
18. Fraser MM, Watson PM, Fraig MM, Kelley JR, Nelson PS, et al. (2005) CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res 65: 6228-6236.
19. Katoh Y, Katoh M, (2009) Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 9: 873-886.
20. Agnelli L, Storti P, Todoerti K, Sammarelli G, Dalla Palma B, et al. (2011) Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations. Am J Hematol 86: E64-66.
21. Suzuki K, Kokuryo T, Senga T, Yokoyama Y, Nagino M, et al. (2010) Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin. Cancer Sci 101: 1163-1169.
22. Wu X, Chen H, Parker B, Rubin E, Zhu T, et al. (2006) HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res 66: 9527-9534.
23. Kobel M, Xu H, Bourne PA, Spaulding BO, Shih Ie M, et al. (2009) IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod Pathol 22: 469-475.
24. Wang S, Li W, Lv S, Wang Y, Liu Z, et al. (2011) Abnormal expression of Nek2 and beta-catenin in breast carcinoma: clinicopathological correlations. Histopathology 59: 631-642.
25. Gnjatic S, Cao Y, Reichelt U, Yekebas EF, Nolker C, et al. (2010) NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer. Int J Cancer 127: 381-393.
26. Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, et al. (2008) Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 215: 245-252.
27. Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, et al. (2009) FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One 4: e4849.
28. Ligato S, Zhao H, Mandich D, Cartun RW, (2008) KOC (K homology domain containing protein overexpressed in cancer) and S100A4-protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies. Diagn Cytopathol 36: 561-567.
29. Zhao H, Mandich D, Cartun RW, Ligato S, (2007) Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol 35: 700-704.
30. Rodriguez JA, Li M, Yao Q, Chen C, Fisher WE, (2005) Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications. World J Surg 29: 297-305.
31. Schaeffer DF, Owen DR, Lim HJ, Buczkowski AK, Chung SW, et al. (2010) Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival. BMC Cancer 10: 59.
32. Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, et al. (2010) FoxM1 is a novel target of a natural agent in pancreatic cancer. Pharm Res 27: 1159-1168.
33. Gray S, Pandha HS, Michael A, Middleton G, Morgan R, (2011) HOX genes in pancreatic development and cancer. Jop 12: 216-219.
34. Wonsey DR, Follettie MT, (2005) Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res 65: 5181-5189.
35. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH, (2007) Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-8300.
36. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, et al. (2005) KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol 29: 188-195.
37. Shimo A, Tanikawa C, Nishidate T, Lin ML, Matsuda K, et al. (2008) Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Cancer Sci 99: 62-70.
38. Nakamura Y, Tanaka F, Haraguchi N, Mimori K, Matsumoto T, et al. (2007) Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 97: 543-549.
39. Hansel DE, Rahman A, Hidalgo M, Thuluvath PJ, Lillemoe KD, et al. (2003) Identification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol 163: 217-229.
40. Mori R, Wang Q, Danenberg KD, Pinski JK, Danenberg PV, (2008) Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate 68: 1555-1560.
41. Weglarz L, Molin I, Orchel A, Parfiniewicz B, Dzierzewicz Z, (2006) Quantitative analysis of the level of p53 and p21(WAF1) mRNA in human colon cancer HT-29 cells treated with inositol hexaphosphate. Acta Biochim Pol 53: 349-356.
42. Ponsioen CY, Vrouenraets SM, van Milligen de Wit AW, Sturm P, Tascilar M, et al. (1999) Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 31: 305-309.
43. Rupp M, Hawthorne CM, Ehya H, (1990) Brushing cytology in biliary tract obstruction. Acta Cytol 34: 221-226.
44. Morales CP, Burdick JS, Saboorian MH, Wright WE, Shay JW, (1998) In situ hybridization for telomerase RNA in routine cytologic brushings for the diagnosis of pancreaticobiliary malignancies. Gastrointest Endosc 48: 402-405.
45. Itoi T, Shinohara Y, Takeda K, Takei K, Ohno H, et al. (2000) Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. Gastrointest Endosc 52: 380-386.
46. Niiyama H, Mizumoto K, Kusumoto M, Ogawa T, Suehara N, et al. (1999) Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms. Cancer 85: 2138-2143.
47. Lankisch TO, Metzger J, Negm AA, Vosskuhl K, Schiffer E, et al. (2011) Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis. Hepatology 53: 875-884.
48. Chapman MH, Tidswell R, Dooley JS, Sandanayake NS, Cerec V, et al. (2012) Whole genome RNA expression profiling of endoscopic biliary brushings provides data suitable for biomarker discovery in cholangiocarcinoma. J Hepatol.
49. Stewart CJ, Burke GM, (2000) Value of p53 immunostaining in pancreatico-biliary brush cytology specimens. Diagn Cytopathol 23: 308-313.
50. Nehls O, Gregor M, Klump B, (2004) Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 24: 139-154.
51. Shi C, Chandrasekaran A, Thuluvath PJ, Karikari C, Argani P, et al. (2009) Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology. J Mol Diagn 11: 583-589.
52. Kipp BR, Barr Fritcher EG, Clayton AC, Gores GJ, Roberts LR, et al. (2010) Comparison of KRAS Mutation Analysis and FISH for Detecting Pancreatobiliary Tract Cancer in Cytology Specimens Collected During Endoscopic Retrograde Cholangiopancreatography. J Mol Diagn [Epub ahead of print].
53. Levy MJ, Clain JE, Clayton A, Halling KC, Kipp BR, et al. (2007) Preliminary experience comparing routine cytology results with the composite results of digital image analysis and fluorescence in situ hybridization in patients undergoing EUS-guided FNA. Gastrointest Endosc 66: 483-490.
54. Fritcher EG, Halling KC, (2010) Advanced cytologic approaches for the diagnosis of pancreatobiliary cancer. Curr Opin Gastroenterol 26: 259-264.